Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 3, 2008	vagelos p roy	Director	Automatic Sell	8,658	n/a
Nov 20, 2007	vagelos p roy	Director	Automatic Sell	138,737	n/a
Oct 1, 2007	vagelos p roy	Director	Automatic Sell	11,560	n/a
May 6, 2013	tessier-lavigne marc	Director	Option Execute	13,334	50.91 - 57.11
May 6, 2013	tessier-lavigne marc	Director	Sell	13,334	260.20 - 264.17
May 8, 2013	terifay robert j	Officer	Sell	8,231	260.86 - 262.06
May 7, 2013	terifay robert j	Officer	Option Execute	16,923	16.80
May 7, 2013	terifay robert j	Officer	Disposition (Non Open Market)	8,692	261.67
Dec 18, 2012	terifay robert j	Officer	Option Execute	5,952	16.80
Nov 23, 2012	terifay robert j	Officer	Sell	9,745	173.90 - 175.09
Nov 21, 2012	terifay robert j	Officer	Option Execute	20,000	16.80
Nov 21, 2012	terifay robert j	Officer	Disposition (Non Open Market)	10,255	173.83
Jul 30, 2012	terifay robert j	Officer	Automatic Sell	23,834	134.99 - 137.58
Jul 27, 2012	terifay robert j	Officer	Option Execute	50,875	16.80 - 21.92
Jul 27, 2012	terifay robert j	Officer	Automatic Sell	27,041	137.39
Feb 1, 2012	terifay robert j	Officer	Automatic Sell	9,439	90.54 - 91.04
Jan 31, 2012	terifay robert j	Officer	Option Execute	23,128	21.92
Jan 31, 2012	terifay robert j	Officer	Automatic Sell	13,689	90.07
Jan 11, 2012	terifay robert j	Officer	Automatic Sell	9,019	74.20
Jan 10, 2012	terifay robert j	Officer	Option Execute	20,000	21.34 - 21.92
Showing 101-120 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.